SCHEMBL22904554

SCHEMBL22904554

O=C1NC(=O)c2c(Oc3cccnc3)cccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ FFAR4 Q5NUL3 1/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ KDM4C Q9H3R0 1/20 0.38
▸ CYP19A1 P11511 3/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37
▸ CASP3 P42574 2/20 0.37
▸ CASP7 P55210 2/20 0.37
▸ CASP2 P42575 1/20 0.37
▸ CASP6 P55212 1/20 0.37
▸ CASP8 Q14790 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22904369 0.76 TDP2 (0.50) LMNATDP1ALDH1A1SMN1; SMN2GRM5
SCHEMBL22909125 0.74 SOD1 (0.40) LMNAALDH1A1SMN1; SMN2CASP3KDM4E
SCHEMBL26473527 0.74 HDAC4 (0.41) CASP3CASP7CASP2CASP6CASP8
SCHEMBL5506330 0.73 MAOA (0.51) LMNAALDH1A1SMN1; SMN2CASP3CASP7
SCHEMBL24701314 0.72 LMNA (0.43) LMNATDP1ALDH1A1SMN1; SMN2FFAR4
SCHEMBL22904576 0.71 DAO (0.50) LMNATDP1ALDH1A1SMN1; SMN2CASP3
SCHEMBL262473 0.70 GSK3B (0.50) TDP1ALDH1A1CASP3CASP7CASP2
SCHEMBL22904147 0.69 MAOB (0.38) LMNASMN1; SMN2CASP3CASP7CASP2
SCHEMBL22909253 0.69 CASP3 (0.45) LMNATDP1ALDH1A1SMN1; SMN2CASP3
SCHEMBL13839612 0.69 KCNA3 (0.39) LMNATDP1ALDH1A1SMN1; SMN2FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 — — WO disclosed
Send feedback